A photo of Kasiani Myers.

Kasiani C. Myers, MD

  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Professor, UC Department of Pediatrics
appointment iconMake An Appointment
MyChart Icon
Existing PatientsMyChart Scheduling
AppointmentsCall Us to ScheduleAppointments1-513-636-3200

About

Biography

I always wanted to be a physician, and specifically a pediatrician. My father is an adult subspecialist, but I was drawn to the care of medically complex children. Now, I enjoy being the bridge between basic research and the clinic.

In my clinical practice, I specialize in treating patients with bone marrow failure and hematopoietic stem cell transplant for non-malignant diseases, with a special emphasis on Shwachman Diamond syndrome and dyskeratosis congenita. My research interests focus on translational and clinical studies in leukemogenesis and bone marrow failure related to these two conditions. I also study the complications of stem cell transplants, including bronchiolitis obliterans and fertility preservation.

I decided to pursue my research interests after my experience as a resident physician and fellow at Cincinnati Children’s. I enjoyed getting to know my patients on the bone marrow transplant and hematology/oncology units. Plus, I was mentored by two of the world’s foremost experts in the field, Dr. Stella Davies and Dr. Richard Harris, right here at Cincinnati Children’s.

After I completed my postdoctoral training, I joined the faculty of the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s within the UC Department of Pediatrics. Now, in addition to clinical work and research, I serve as the co-director of the North American Shwachman Diamond Syndrome Registry.

BS: University of Michigan, Ann Arbor, MI, 2000.

MD: Case Western Reserve University, Cleveland, OH, 2004.

Post-Doctoral: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Certification: Pediatrics, 2007.

Services and Specialties

Research Areas

Additional Languages

French, Greek

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemias. Venkatasubramanian, M; Schwartz, L; Ramachandra, N; Bennett, J; Subramanian, KR; Chen, X; Gordon-Mitchell, S; Fromowitz, A; Pradhan, K; Shechter, D; Grimes, HL; Starczynowski, DT; Verma, A; Salomonis, N. Science Translational Medicine. 2025; 17:eadr1471.

Kinetics of DNases after hematopoietic stem cell transplant. Ibrahimova, A; Luebbering, N; Langenberg, L; Abdullah, S; Strecker, L; Lake, KE; Lane, A; Webster, A; Myers, KC; Jodele, S; Davies, SM. 2025; 2:100055.

Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Mehta, PA; Nelson, A; Loveless, S; Lane, A; Fukuda, T; Teusink-Cross, A; Elder, D; Lagory, D; Miller, E; Cancelas, JA; Edwards, S; Chihanga, T; Wells, SI; Davies, SM. Blood Advances. 2025; 9:1927-1939.

Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Merli, P; Jodele, S; Cook, E; Myers, KC; Lane, A; Ryhänen, S; Cefalo, MP; Quagliarella, F; Davies, SM; Teusink-Cross, A; Kohorst, M; Corsetti, T; Locatelli, F; Sabulski, A. Bone Marrow Transplantation. 2025; 60:406-411.

Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem Cells. Myers, KC; Davies, SM; Lutzko, C; Wahle, R; Grier, DD; Aubert, G; Norris, K; Baird, DM; Koga, M; Ko, AC; Amano, T; Amano, M; Yu, H; Ko, MS H. 2025; 4:EVIDoa2400252.

Oxidative Stress Early After Hematopoietic Stem Cell Transplant. Cook, E; Langenberg, L; Luebbering, N; Ibrahimova, A; Myers, KC; Sabulski, A; Dandoy, C; Lake, K; Ziady, A; Lane, A; Webster, A; Abdullah, S; Jodele, S; Davies, SM. Transplantation and Cellular Therapy. 2025; 31:135.e1-135.e10.

Real-World Assessment of Patient Adherence to the Late Effects Screening Recommendations Among Hematopoietic Cell Transplantation Survivors. Bhatt, N; Hellewell, EM; Ng, K; Gooley, TA; Taylor, AO; Hong, S; Sung, A; Ahmed, N; Morey, C; Fitzmaurice, S; Yingling, S; Edgar, C; Browning, A; Lee, CJ. Transplantation and Cellular Therapy. 2025; 31:s364-s365.

Frequent Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Brief Transpire Report. Ashraf, A; Lake, KE; Myers, KC; Towe, C; Cooper, R; Edwards, MS L; Hils, B; Davies, SM; Koo, DJ. Transplantation and Cellular Therapy. 2025; 31:s149-s150.

Beyond Graft-Vs-Host Disease: The Role of Cellular Senescence in Persistent Liver Injury in Fanconi Anemia after HSCT. Koo, DJ; Miller, E; O'Conner, A; Campbell, KM; Grompe, M; Myers, KC; Mehta, PA; Davies, SM. Transplantation and Cellular Therapy. 2025; 31:s311-s312.

Beyond Survival: Assessing Renal and Cardiovascular Health in Fanconi Anemia Adolescents and Young Adults Post-Stem Cell Transplant. Bender, J; Davies, SM; Myers, KC; Benoit, SW. Transplantation and Cellular Therapy. 2025; 31:s375-s376.

From the Blog

First Gene Therapy Trial for Telomere Biology Disorders Shows Promising Results
Cancer

First Gene Therapy Trial for Telomere Biology Disorders Shows Promising Results

Kasiani C. Myers, MD2/25/2025

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating
Give Today

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026

© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.

U.S. News & World Report Honor Roll Badge for Top Children's Hospital.Best Places to Work.America's Best Large Employers